Free Trial

M & L Capital Management Ltd Makes New $21.62 Million Investment in Synopsys, Inc. (NASDAQ:SNPS)

Synopsys logo with Computer and Technology background
Remove Ads

M & L Capital Management Ltd acquired a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 44,550 shares of the semiconductor company's stock, valued at approximately $21,623,000. Synopsys makes up approximately 5.3% of M & L Capital Management Ltd's investment portfolio, making the stock its 6th biggest position.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SNPS. Peloton Wealth Strategists grew its position in shares of Synopsys by 221.2% during the third quarter. Peloton Wealth Strategists now owns 2,881 shares of the semiconductor company's stock worth $1,459,000 after acquiring an additional 1,984 shares during the last quarter. Swiss National Bank grew its position in shares of Synopsys by 0.7% during the third quarter. Swiss National Bank now owns 454,800 shares of the semiconductor company's stock worth $230,306,000 after acquiring an additional 3,200 shares during the last quarter. Parnassus Investments LLC purchased a new position in shares of Synopsys during the third quarter worth approximately $633,469,000. Nordea Investment Management AB grew its position in shares of Synopsys by 15.9% during the fourth quarter. Nordea Investment Management AB now owns 1,043,995 shares of the semiconductor company's stock worth $509,261,000 after acquiring an additional 143,284 shares during the last quarter. Finally, James Hambro & Partners LLP grew its position in shares of Synopsys by 30.9% during the fourth quarter. James Hambro & Partners LLP now owns 201,460 shares of the semiconductor company's stock worth $97,725,000 after acquiring an additional 47,527 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company's stock.

Remove Ads

Synopsys Stock Performance

SNPS stock traded up $17.65 during trading on Friday, hitting $446.23. The stock had a trading volume of 1,118,063 shares, compared to its average volume of 1,228,387. The company's 50 day moving average price is $495.89 and its two-hundred day moving average price is $508.30. Synopsys, Inc. has a 1-year low of $425.73 and a 1-year high of $624.80. The stock has a market cap of $69.00 billion, a price-to-earnings ratio of 30.73, a price-to-earnings-growth ratio of 3.23 and a beta of 1.16.

Insider Activity at Synopsys

In related news, insider Geus Aart De sold 15,705 shares of the business's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $444.42, for a total value of $6,979,616.10. Following the completion of the transaction, the insider now owns 116,671 shares of the company's stock, valued at approximately $51,850,925.82. The trade was a 11.86 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the completion of the transaction, the chief executive officer now directly owns 70,922 shares of the company's stock, valued at $32,890,077.50. The trade was a 13.81 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 47,909 shares of company stock valued at $22,794,835. 0.62% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on SNPS. Needham & Company LLC reiterated a "buy" rating and issued a $650.00 price objective on shares of Synopsys in a research report on Thursday, February 27th. Piper Sandler lowered their price objective on shares of Synopsys from $655.00 to $653.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. Rosenblatt Securities reiterated a "buy" rating and issued a $660.00 price objective on shares of Synopsys in a research report on Tuesday, February 25th. Wells Fargo & Company lowered their price objective on shares of Synopsys from $540.00 to $520.00 and set an "equal weight" rating on the stock in a research report on Thursday, February 27th. Finally, Redburn Atlantic began coverage on shares of Synopsys in a research report on Monday, January 13th. They issued a "buy" rating and a $600.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $638.58.

Get Our Latest Stock Report on Synopsys

About Synopsys

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Stories

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

How To Invest in Crypto as A Complete BEGINNER in 2025

How To Invest in Crypto as A Complete BEGINNER in 2025

In this episode, Crypto Capital’s Eric Wade breaks down everything you need to know about how to start investing in cryptocurrency, the safest ways to buy Bitcoin and altcoins, and whether crypto shou

Related Videos

7 Stocks to Benefit From Trump’s Tariffs in 2025
7 Large-Cap Stocks Headed for Strong, Steady Gains in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads